Literature DB >> 16837309

Minimum protein requirements in liver cirrhosis determined by nitrogen balance measurements at three levels of protein intake.

G R Swart1, J W van den Berg, J K van Vuure, T Rietveld, D L Wattimena, M Frenkel.   

Abstract

Nitrogen balance at three levels of protein intake was measured in eight patients with cirrhosis of the liver; moreover, at each level of protein intake, the effects on nitrogen balance of branched-chain amino-acid enriched protein and natural protein were compared. From these nitrogen balance data, minimum protein requirements were calculated by linear regression analysis. The patients were in a negative nitrogen balance on a 40 g protein diet (-0.75 +/- 0.15 gN.), and in positive nitrogen balance on 60 g (+1.23 +/- 0.22 gN.) or 80 g of protein per day (+2.77 +/- 0.20 g N.). Their mean minimum protein requirement (48 +/- 5 g of protein/day or 0.75 g/kg/day) is higher than expected in healthy people; the safe level of protein intake (mean + 2 sd) is 58 g per day or 1.2 g/kg/day. Nitrogen balances and protein requirements were not different on branched-chain amino-acid enriched diets. The physical condition of the patients improved when they came into positive nitrogen balance; the higher rates of protein intake were well tolerated without onset of encephalopathy. We conclude that protein requirements are elevated in cirrhosis of the liver; diets supplying less than 60 g of protein per day should not be prescribed in long term treatment of cirrhotic patients.

Entities:  

Year:  1989        PMID: 16837309     DOI: 10.1016/0261-5614(89)90008-3

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  20 in total

1.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

Review 2.  Malnutrition and nutrition support in patients with liver disease.

Authors:  John Saunders; Anna Brian; Mark Wright; Mike Stroud
Journal:  Frontline Gastroenterol       Date:  2010-06-15

Review 3.  Pathophysiology and clinical basis of prevention and treatment of complications of chronic liver disease.

Authors:  S Wagner; H U Lautz; M J Müller; F W Schmidt
Journal:  Klin Wochenschr       Date:  1991-02-06

4.  Protein restriction in hepatic encephalopathy is appropriate for selected patients: a point of view.

Authors:  Douglas L Nguyen; Timothy Morgan
Journal:  Hepatol Int       Date:  2014-09-01       Impact factor: 6.047

Review 5.  EASL Clinical Practice Guidelines on nutrition in chronic liver disease.

Authors: 
Journal:  J Hepatol       Date:  2018-08-23       Impact factor: 25.083

6.  Oral supplementation with branched-chain amino acids improves survival rate of rats with carbon tetrachloride-induced liver cirrhosis.

Authors:  K Kajiwara; M Okuno; T Kobayashi; N Honma; T Maki; M Kato; H Ohnishi; Y Muto; H Moriwaki
Journal:  Dig Dis Sci       Date:  1998-07       Impact factor: 3.199

7.  Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial.

Authors:  O Riggio; F Ariosto; M Merli; M Caschera; A Zullo; G Balducci; V Ziparo; G Pedretti; F Fiaccadori; E Bottari
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

8.  Preservation of portal pressure improves growth and metabolic profile in the male portacaval-shunted rat.

Authors:  Srinivasan Dasarathy; Kevin D Mullen; Hari S Conjeevaram; Kristine Kaminsky-Russ; Laurie A Wills; Arthur J McCullough
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

Review 9.  Role of Nutrition and Muscle in Cirrhosis.

Authors:  Ragesh B Thandassery; Aldo J Montano-Loza
Journal:  Curr Treat Options Gastroenterol       Date:  2016-06

Review 10.  Hepatology - Guidelines on Parenteral Nutrition, Chapter 16.

Authors:  M Plauth; T Schuetz
Journal:  Ger Med Sci       Date:  2009-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.